At the time of writing, Medicinova Inc [MNOV] stock is trading at $2.28, up 49.02%. An important factor to consider is whether the stock is rising or falling in short-term value. The MNOV shares have gain 41.61% over the last week, with a monthly amount glided 28.81%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Medicinova Inc [NASDAQ: MNOV] stock has seen the most recent analyst activity on March 10, 2021, when Maxim Group initiated its Buy rating and assigned the stock a price target of $15. On March 28, 2018, B. Riley FBR Inc. initiated with a Buy rating and assigned a price target of $22 on the stock. Credit Suisse started tracking the stock assigning a Outperform rating. Ladenburg Thalmann reiterated its recommendation of a Buy and reduced its price target to $6 on January 04, 2013. MLV & Co downgraded its rating to Hold for this stock on May 24, 2012. In a note dated October 18, 2011, MLV Capital reiterated an Buy rating on this stock and revised its target price from $13 to $6.
For the past year, the stock price of Medicinova Inc fluctuated between $1.12 and $2.16. Medicinova Inc [NASDAQ: MNOV] shares were valued at $2.28 at the most recent close of the market.
Analyzing the MNOV fundamentals
Gross Profit Margin for this corporation currently stands at 0.9% with Operating Profit Margin at -5093.0%, Pretax Profit Margin comes in at -35.97%, and Net Profit Margin reading is -35.99%. To continue investigating profitability, this company’s Return on Assets is posted at -0.14, Equity is -0.13 and Total Capital is -19.95. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.8400 points at the first support level, and at 1.3900 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.6400, and for the 2nd resistance point, it is at 2.9900.
Ratios To Look Out For
It is important to note that Medicinova Inc [NASDAQ:MNOV] has a current ratio of 18.24. On the other hand, the Quick Ratio is 18.24, and the Cash Ratio is 17.78. Considering the valuation of this stock, the price to sales ratio is 111.82, the price to book ratio is 1.95.
